The Fourth Circuit questioned a biotechnology company’s claim that it was wrongly deprived of tax credits for drug research, asking Thursday why the company rejected the U.S. Tax Court’s ruling that it should have included clinical expenses in its calculation.
4th Circ. Skeptical Of Biotech Co.’s Tax Credit Claim
by usoftax_admin | Jan 25, 2024 | Tax News